(FLS) Flowserve - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US34354P1057
Stock: Pumps, Seals, Valves, Services
Total Rating 67
Risk 85
Buy Signal -0.74
| Risk 5d forecast | |
|---|---|
| Volatility | 38.5% |
| Relative Tail Risk | -5.96% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.23 |
| Alpha | 35.08 |
| Character TTM | |
|---|---|
| Beta | 1.831 |
| Beta Downside | 1.776 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.76% |
| CAGR/Max DD | 0.95 |
EPS (Earnings per Share)
Revenue
Description: FLS Flowserve March 05, 2026
Flowserve Corporation (FLS) designs, manufactures, distributes, and services industrial flow management equipment globally. The company operates through two segments: Flowserve Pumps Division (FPD) and Flow Control Division (FCD).
FLS provides custom and industrial pumps, mechanical seals, and related services. These products are critical for infrastructure, as they manage the movement of liquids and gases in various industrial processes.
The company also offers engineered-to-order and configured-to-order isolation valves, control valves, and valve automation products. These components are essential for controlling fluid flow in complex industrial systems.
Flowserve serves diverse sectors including oil and gas, power generation, chemical, and water management. Industrial machinery companies often have long sales cycles due to the custom nature and high cost of their products.
FLS distributes its products via direct sales, distributors, and sales representatives. Understanding the companys market position and competitive landscape can be further explored with ValueRay.
Headlines to watch out for
- Oil and gas capital expenditure drives pump and valve demand
- Industrial project delays impact equipment orders
- Raw material cost fluctuations compress manufacturing margins
- Global infrastructure spending boosts water management segment
- Competition from low-cost manufacturers erodes market share
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 346.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 1.36 > 1.0 |
| NWC/Revenue: 32.58% < 20% (prev 31.52%; Δ 1.07% < -1%) |
| CFO/TA 0.09 > 3% & CFO 505.9m > Net Income 346.2m |
| Net Debt (1.15b) to EBITDA (675.8m): 1.70 < 3 |
| Current Ratio: 2.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (128.4m) vs 12m ago -2.98% < -2% |
| Gross Margin: 34.30% > 18% (prev 0.32%; Δ 3.40k% > 0.5%) |
| Asset Turnover: 84.38% > 50% (prev 82.86%; Δ 1.53% > 0%) |
| Interest Coverage Ratio: 7.47 > 6 (EBITDA TTM 675.8m / Interest Expense TTM 77.7m) |
Altman Z'' 6.09
| A: 0.27 (Total Current Assets 3.04b - Total Current Liabilities 1.50b) / Total Assets 5.71b |
| B: 0.75 (Retained Earnings 4.26b / Total Assets 5.71b) |
| C: 0.10 (EBIT TTM 580.3m / Avg Total Assets 5.60b) |
| D: 1.13 (Book Value of Equity 3.91b / Total Liabilities 3.45b) |
| Altman-Z'' Score: 6.09 = AAA |
Beneish M -3.28
| DSRI: 0.78 (Receivables 1.03b/1.28b, Revenue 4.73b/4.56b) |
| GMI: 0.94 (GM 34.30% / 32.16%) |
| AQI: 0.98 (AQ_t 0.34 / AQ_t-1 0.34) |
| SGI: 1.04 (Revenue 4.73b / 4.56b) |
| TATA: -0.03 (NI 346.2m - CFO 505.9m) / TA 5.71b) |
| Beneish M-Score: -3.28 (Cap -4..+1) = AA |
What is the price of FLS shares?
As of March 15, 2026, the stock is trading at USD 78.77 with a total of 1,272,286 shares traded.
Over the past week, the price has changed by -2.54%, over one month by -17.17%, over three months by +3.74% and over the past year by +58.45%.
Over the past week, the price has changed by -2.54%, over one month by -17.17%, over three months by +3.74% and over the past year by +58.45%.
Is FLS a buy, sell or hold?
Flowserve has received a consensus analysts rating of 4.55.
Therefore, it is recommended to buy FLS.
- StrongBuy: 8
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the FLS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 95.8 | 21.6% |
| Analysts Target Price | 95.8 | 21.6% |
FLS Fundamental Data Overview March 13, 2026
P/E Trailing = 29.8371
P/E Forward = 18.9753
P/S = 2.1196
P/B = 4.5744
P/EG = 1.8981
Revenue TTM = 4.73b USD
EBIT TTM = 580.3m USD
EBITDA TTM = 675.8m USD
Long Term Debt = 1.53b USD (from longTermDebt, last quarter)
Short Term Debt = 85.5m USD (from shortTermDebt, last quarter)
Debt = 1.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.15b USD (from netDebt column, last quarter)
Enterprise Value = 11.17b USD (10.02b + Debt 1.91b - CCE 760.2m)
Interest Coverage Ratio = 7.47 (Ebit TTM 580.3m / Interest Expense TTM 77.7m)
EV/FCF = 25.69x (Enterprise Value 11.17b / FCF TTM 435.0m)
FCF Yield = 3.89% (FCF TTM 435.0m / Enterprise Value 11.17b)
FCF Margin = 9.20% (FCF TTM 435.0m / Revenue TTM 4.73b)
Net Margin = 7.32% (Net Income TTM 346.2m / Revenue TTM 4.73b)
Gross Margin = 34.30% ((Revenue TTM 4.73b - Cost of Revenue TTM 3.11b) / Revenue TTM)
Gross Margin QoQ = 34.80% (prev 34.55%)
Tobins Q-Ratio = 1.96 (Enterprise Value 11.17b / Total Assets 5.71b)
Interest Expense / Debt = 1.02% (Interest Expense 19.6m / Debt 1.91b)
Taxrate = 29.61% (155.6m / 525.4m)
NOPAT = 408.5m (EBIT 580.3m * (1 - 29.61%))
Current Ratio = 2.03 (Total Current Assets 3.04b / Total Current Liabilities 1.50b)
Debt / Equity = 0.87 (Debt 1.91b / totalStockholderEquity, last quarter 2.19b)
Debt / EBITDA = 1.70 (Net Debt 1.15b / EBITDA 675.8m)
Debt / FCF = 2.64 (Net Debt 1.15b / FCF TTM 435.0m)
Total Stockholder Equity = 2.19b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.18% (Net Income 346.2m / Total Assets 5.71b)
RoE = 15.81% (Net Income TTM 346.2m / Total Stockholder Equity 2.19b)
RoCE = 15.62% (EBIT 580.3m / Capital Employed (Equity 2.19b + L.T.Debt 1.53b))
RoIC = 11.04% (NOPAT 408.5m / Invested Capital 3.70b)
WACC = 10.75% (E(10.02b)/V(11.93b) * Re(12.66%) + D(1.91b)/V(11.93b) * Rd(1.02%) * (1-Tc(0.30)))
Discount Rate = 12.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.42%
[DCF] Terminal Value 69.21% ; FCFF base≈398.7m ; Y1≈409.6m ; Y5≈457.9m
[DCF] Fair Price = 31.87 (EV 5.21b - Net Debt 1.15b = Equity 4.06b / Shares 127.3m; r=10.75% [WACC]; 5y FCF grow 2.72% → 2.90% )
EPS Correlation: 78.86 | EPS CAGR: 109.0% | SUE: 2.46 | # QB: 3
Revenue Correlation: 88.61 | Revenue CAGR: 11.19% | SUE: -1.19 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.97 | Chg7d=-0.001 | Chg30d=-0.039 | Revisions Net=-2 | Analysts=11
EPS current Year (2026-12-31): EPS=4.14 | Chg7d=+0.013 | Chg30d=+0.156 | Revisions Net=+8 | Growth EPS=+13.7% | Growth Revenue=+5.9%
EPS next Year (2027-12-31): EPS=4.68 | Chg7d=+0.017 | Chg30d=+0.268 | Revisions Net=+5 | Growth EPS=+13.1% | Growth Revenue=+6.1%
[Analyst] Revisions Ratio: -0.33 (2 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.3% (Discount Rate 12.7% - Earnings Yield 3.4%)
[Growth] Growth Spread = -6.0% (Analyst 3.3% - Implied 9.3%)
P/E Forward = 18.9753
P/S = 2.1196
P/B = 4.5744
P/EG = 1.8981
Revenue TTM = 4.73b USD
EBIT TTM = 580.3m USD
EBITDA TTM = 675.8m USD
Long Term Debt = 1.53b USD (from longTermDebt, last quarter)
Short Term Debt = 85.5m USD (from shortTermDebt, last quarter)
Debt = 1.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.15b USD (from netDebt column, last quarter)
Enterprise Value = 11.17b USD (10.02b + Debt 1.91b - CCE 760.2m)
Interest Coverage Ratio = 7.47 (Ebit TTM 580.3m / Interest Expense TTM 77.7m)
EV/FCF = 25.69x (Enterprise Value 11.17b / FCF TTM 435.0m)
FCF Yield = 3.89% (FCF TTM 435.0m / Enterprise Value 11.17b)
FCF Margin = 9.20% (FCF TTM 435.0m / Revenue TTM 4.73b)
Net Margin = 7.32% (Net Income TTM 346.2m / Revenue TTM 4.73b)
Gross Margin = 34.30% ((Revenue TTM 4.73b - Cost of Revenue TTM 3.11b) / Revenue TTM)
Gross Margin QoQ = 34.80% (prev 34.55%)
Tobins Q-Ratio = 1.96 (Enterprise Value 11.17b / Total Assets 5.71b)
Interest Expense / Debt = 1.02% (Interest Expense 19.6m / Debt 1.91b)
Taxrate = 29.61% (155.6m / 525.4m)
NOPAT = 408.5m (EBIT 580.3m * (1 - 29.61%))
Current Ratio = 2.03 (Total Current Assets 3.04b / Total Current Liabilities 1.50b)
Debt / Equity = 0.87 (Debt 1.91b / totalStockholderEquity, last quarter 2.19b)
Debt / EBITDA = 1.70 (Net Debt 1.15b / EBITDA 675.8m)
Debt / FCF = 2.64 (Net Debt 1.15b / FCF TTM 435.0m)
Total Stockholder Equity = 2.19b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.18% (Net Income 346.2m / Total Assets 5.71b)
RoE = 15.81% (Net Income TTM 346.2m / Total Stockholder Equity 2.19b)
RoCE = 15.62% (EBIT 580.3m / Capital Employed (Equity 2.19b + L.T.Debt 1.53b))
RoIC = 11.04% (NOPAT 408.5m / Invested Capital 3.70b)
WACC = 10.75% (E(10.02b)/V(11.93b) * Re(12.66%) + D(1.91b)/V(11.93b) * Rd(1.02%) * (1-Tc(0.30)))
Discount Rate = 12.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.42%
[DCF] Terminal Value 69.21% ; FCFF base≈398.7m ; Y1≈409.6m ; Y5≈457.9m
[DCF] Fair Price = 31.87 (EV 5.21b - Net Debt 1.15b = Equity 4.06b / Shares 127.3m; r=10.75% [WACC]; 5y FCF grow 2.72% → 2.90% )
EPS Correlation: 78.86 | EPS CAGR: 109.0% | SUE: 2.46 | # QB: 3
Revenue Correlation: 88.61 | Revenue CAGR: 11.19% | SUE: -1.19 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.97 | Chg7d=-0.001 | Chg30d=-0.039 | Revisions Net=-2 | Analysts=11
EPS current Year (2026-12-31): EPS=4.14 | Chg7d=+0.013 | Chg30d=+0.156 | Revisions Net=+8 | Growth EPS=+13.7% | Growth Revenue=+5.9%
EPS next Year (2027-12-31): EPS=4.68 | Chg7d=+0.017 | Chg30d=+0.268 | Revisions Net=+5 | Growth EPS=+13.1% | Growth Revenue=+6.1%
[Analyst] Revisions Ratio: -0.33 (2 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.3% (Discount Rate 12.7% - Earnings Yield 3.4%)
[Growth] Growth Spread = -6.0% (Analyst 3.3% - Implied 9.3%)